MUMBAI, 1st JUNE, 2022 (GPN): The 8th edition of PharmaLytica Expo opened its doors to industry professionals at the Bombay Exhibition Centre, Mumbai today. The event had a grand opening in the presence of key dignitaries Mr. K. G….
Pipeline™ Embolization Device (PED) Warranty Program to define the standard of care for flow diversion treatment of brain aneurysms MUMBAI, INDIA, 01 JUNE, 2022 (GPN)–– India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE:MDT)…
MUMBAI, MAY 2022 (GPN): Informa Markets in India is going to organise the 8th edition of the PharmaLytica Expo from 1st-3rd June, 2022, in Mumbai. 1st June is considered as the Global Exhibition Day. The…
FOR MORE PHOTOS OF THE EVENT VISIT: HERE MUMBAI, MAY 30, 2022 (GPN): The findings of the Tobacco Control Policy (TCP) third round survey in India revealed some alarming facts about tobacco use and the implementation…
While JB’s look has changed, the values remain! Mumbai – 30th May 2022 (GPN): JB Chemicals & Pharmaceuticals Limited, the fastest growing pharmaceuticals company in India, has emerged in a new avatar as JB, retaining…
MUMBAI, 25 MAY, 2022(GPN): A mother had lost her 12-year old child in an accident and it was after many years that a ray of happiness broke through the shadows of sorrow when she became pregnant…
Investment with representation on Board of Directors, technical know-how transfer MUMBAI, 23 MAY, 2022 (GPN): Karkinos Healthcare, a technology-driven, oncology focussed managed health care platform, today announced that Mayo Clinic has invested a minority stake in the…
MUMBAI, 19 MAY, 2022 (GPN): The increase in young people having heart attacks is dramatically on the rise. Experts say this is due to poor lifestyle choices such as lack of exercise and a bad…
~OSSGROW is India’s first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country~ MUMBAI, 19 MAY, 2022 (GPN): – Regrow Biosciences, an Indian-centric global biotech company, is glad…
An extended half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A, resulting in lower weekly infusion rates than standard FVIII, providing excellent prophylactic coverage · Adynovate in combination with MYPKFIT®offers personalized treatment and enables HCPs and…
